For the quarter ended December 2025, Patrick Industries (PATK) reported revenue of $924.17 million, up 9.2% over the same period last year. EPS came in at $0.84, compared to $0.52 in the year-ago quarter.The reported revenue represents a surprise of +6.54% over the Zacks Consensus Estimate of $867.48 million. With the consensus EPS estimate being $0.74, the EPS surprise was +13.51%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to de ...

Modine (MOD) reported $805 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 30.5%. EPS of $1.19 for the same period compares to $0.92 a year ago.The reported revenue represents a surprise of +5.9% over the Zacks Consensus Estimate of $760.14 million. With the consensus EPS estimate being $0.99, the EPS surprise was +19.96%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine the ...

For the quarter ended December 2025, Techne (TECH) reported revenue of $295.88 million, down 0.4% over the same period last year. EPS came in at $0.46, compared to $0.42 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $292.03 million, representing a surprise of +1.32%. The company delivered an EPS surprise of +8.24%, with the consensus EPS estimate being $0.43.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how ...

Procter & Gamble (PG) reported $22.21 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 1.5%. EPS of $1.88 for the same period compares to $1.88 a year ago.The reported revenue represents a surprise of -0.36% over the Zacks Consensus Estimate of $22.29 billion. With the consensus EPS estimate being $1.87, the EPS surprise was +0.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Core Insights - Albemarle Corporation reported strong third-quarter results for 2025, with adjusted EBITDA increasing year-over-year despite lower lithium prices, highlighting the company's operational strength and cost management efforts [3][6][8]. Financial Performance - Net sales for Q3 2025 were $1.3 billion, a decrease of 3% from $1.4 billion in Q3 2024, primarily due to lower pricing in Energy Storage, although volumes increased [4][6]. - Adjusted EBITDA for Q3 2025 was $226 million, up $14 million from the previous year, driven by lower input costs and ongoing cost reduction initiatives [6][8]. - The net loss attributable to Albemarle was $161 million, a significant improvement from a loss of $1.07 billion in the prior year, mainly due to restructuring charges recorded in the previous period [4][6][8]. - The diluted loss per share attributable to common shareholders was $(1.72), compared to $(9.45) in Q3 2024, reflecting an 81.8% improvement [4][8]. Segment Performance - Energy Storage segment net sales were $709 million, down 8% year-over-year, with a 16% decrease in pricing offset by an 8% increase in volumes [7][8]. - Specialties segment net sales increased slightly to $345 million, a 0.8% rise, with adjusted EBITDA rising 34.2% to $76 million due to reduced manufacturing costs [10][11]. - Ketjen segment net sales were $254 million, up 3.7% year-over-year, with adjusted EBITDA decreasing slightly to $34 million due to lower prices and higher input costs [11][12]. Cash Flow and Capital Expenditures - Cash from operations for Q3 2025 was $356 million, a 57% increase year-over-year, contributing to a year-to-date total of $894 million, up 29% [8][19]. - The company reduced its full-year 2025 capital expenditures outlook to approximately $600 million, down from $1.7 billion in 2024, reflecting a focus on sustaining existing assets [19][20]. Outlook - Albemarle is enhancing its full-year 2025 outlook, expecting results to be towards the higher end of previously published scenarios due to better-than-expected performance in Energy Storage and lithium market pricing [12][14]. - The company anticipates achieving positive free cash flow of $300 to $400 million for the full year 2025 [8][19].

Core Insights - Somnigroup International (SGI) is expected to report quarterly earnings of $0.85 per share, reflecting a 3.7% increase year over year, with revenues projected at $2.07 billion, a significant 59% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 4.2% in the last 30 days, indicating analysts' reassessment of their initial projections [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Direct' at $1.32 billion, representing a remarkable increase of 316.1% from the previous year [5]. - 'Net Sales- Wholesale' is projected to be $716.71 million, indicating a decrease of 27% year over year [5]. - 'Net Sales- International' is expected to reach $308.79 million, reflecting an 8.5% increase from the prior year [5]. Regional Sales Estimates - 'Net Sales- North America' is anticipated to be $732.72 million, showing a decline of 27.8% from the previous year [6]. - 'Net Sales- North America- Wholesale' is forecasted at $605.19 million, indicating a year-over-year decrease of 31.1% [6]. - 'Net Sales- International- Direct' is estimated at $196.52 million, reflecting an 8.4% increase from the prior year [6]. Additional Sales Insights - 'Net Sales- International- Wholesale' is projected to be $111.52 million, suggesting a year-over-year increase of 7.9% [7]. - 'Net Sales- North America- Direct' is expected to reach $107.39 million, indicating a decline of 21.6% year over year [7]. Market Performance - SGI shares have shown a return of -4.4% over the past month, contrasting with the Zacks S&P 500 composite's +1% change [7]. - With a Zacks Rank 2 (Buy), SGI is anticipated to outperform the overall market in the near future [7].

Core Insights - BIC's Q3 2025 net sales were 519 million euros, reflecting a slight increase of +0.3% at constant currency but a decrease of -3.3% when excluding Tangle Teezer [2][4] - The company announced the divestiture of its Cello activities in India, indicating a strategic shift as the growth and profitability of these operations no longer aligned with BIC's ambitions [3][21][22] - Following a soft performance in Q3, BIC revised its FY 2025 outlook, anticipating net sales growth at constant currency in the range of -1% to -1.5% and an adjusted EBIT margin around 13.7% [7][11][8] Financial Performance - Q3 2025 net sales by division showed varied performance: - Human Expression: 192 million euros, down -0.5% at constant currency [6][10] - Flame for Life: 175 million euros, down -4.3% at constant currency [6][15] - Blade Excellence: 146 million euros, up +7.4% at constant currency, but down -6.1% excluding Tangle Teezer [6][20] - For the first nine months of 2025, net sales were 1,595 million euros, a decrease of -5.0% compared to the same period in 2024 [4][25] Regional Performance - In Europe, Q3 net sales were relatively flat at constant currency, with strong Back-to-School sales in Eastern Europe, Germany, and the UK, but weaker performance in Southern Europe [12][24] - North America experienced high-single-digit growth in Q3, driven by a solid performance in the US stationery market, although this was partially offset by poor results in other segments [12][24] - Latin America saw a decline in Q3 net sales, primarily due to competitive pressures in Mexico, while Brazil showed slight improvement [12][24] Strategic Actions - The divestiture of Cello activities in India is part of a broader strategy to sharpen focus on operations and invest in markets with a winning strategy [21][23] - CEO Rob Versloot emphasized the need for swift action to define a clear plan for BIC's future, indicating a commitment to improving operational performance [6][8][23]

Medline is telling prospective investors in its IPO that it had about $13.5 billion in net sales in the first half of 2025, an increase of roughly 9.7% from last year, according to sources https://t.co/IVg10OL6a6 ...

Financial Metrics - Gross profit margin is calculated as net sales minus the cost of goods sold (COGS) [1]

Core Insights - Amcor reported $5.08 billion in revenue for the quarter ended June 2025, marking a year-over-year increase of 43.8% [1] - The EPS for the same period was $0.20, slightly down from $0.21 a year ago [1] - Revenue fell short of the Zacks Consensus Estimate of $5.17 billion, resulting in a surprise of -1.76% [1] - The company experienced an EPS surprise of -4.76%, with the consensus EPS estimate being $0.21 [1] Financial Performance Metrics - Net Sales for Flexible Packaging reached $3.21 billion, exceeding the two-analyst average estimate of $2.71 billion, representing a year-over-year change of +19.3% [4] - Net Sales for Rigid Packaging amounted to $1.88 billion, significantly surpassing the $765.86 million average estimate, with a year-over-year change of +121.1% [4] - Adjusted EBIT for Flexibles was reported at $450 million, compared to the average estimate of $410.01 million [4] - Adjusted EBIT for Rigid Packaging was $204 million, exceeding the average estimate of $68.86 million [4] - Corporate expenses showed an adjusted EBIT of -$43 million, compared to the average estimate of -$29.78 million [4] Stock Performance - Amcor's shares have returned +5.1% over the past month, outperforming the Zacks S&P 500 composite's +3.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]